This week, we will discuss some groundbreaking work on elucidating the adaptive and maladaptive cellular transcription and gene activation of the kidney in healthy and diseased states.
news
Day 2 was less exciting: we cover 1 IgA trial (Ravulizumab) along with another calcimimetic, and a pentoxifylline meta-analysis.
news, Background
Day of Kidney Week 2026. The NephJC crew discusses 6 studies, including some blockbustr IgA news.
Background
This week, we will discuss whether decreased donor transplantation improves mortality in all patients. In this target trial emulation standard donor, extended donor, donation after brain death and donation after cardiac death outcomes are compared across age groups with different co-morbid conditions.
Background
This week, we will discuss the best schedule for tapering steroids in adult patients with podocytopathies (MCD/FSGS).
